Alinity m
Device Molecular Diagnostics
PDI 00884999048034
General payments
$3,904,690
Research payments
$9,430,185
Through program year 2025, $3,904,690 in general payments and $9,430,185 in research payments were reported against Alinity m (Molecular Diagnostics).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $679,680 | 283 |
| 2025 | Research | $76,525 | 2 |
| 2024 | General | $657,577 | 140 |
| 2024 | Research | $81,645 | 3 |
| 2023 | General | $2,547,291 | 200 |
| 2023 | Research | $4,762,758 | 635 |
| 2022 | General | $17,726 | 31 |
| 2022 | Research | $10,493 | 17 |
| 2021 | General | $2,416 | 19 |
| 2021 | Research | $4,498,764 | 339 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 30 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 25 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
673 general · 996 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.